Key Drivers
- Strong Cash Flow
- Moderate Leverage
- Intangible Heavy
AIAI Summary
ELV has shifted from a “broken” managed-care name to a recovery-and-rerating story after its Q1 beat and raised guidance, but the stock's next leg higher depends on sustained medical-cost control because much of the rebound is already priced in and any claims re-acceleration or legal/regulatory setback could quickly cap upside.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong Cash Flow
- •Moderate Leverage
- •Intangible Heavy
ELV looks fundamentally sound, with solid 13% ROE/ROIC, strong free cash flow, and manageable leverage, but modest margins and a heavy intangible asset base temper the overall quality.
Price Behavior
Key Price Behavior Insights:
- •Uptrend intact
- •Resistance overhead
- •Support holding
ELV remains in a constructive uptrend after a strong last month rally from $323.05 to $392.68, but it needs to hold $378.07-$381.75 and clear the $399.64-$400.00 resistance zone to confirm further upside.
Up more than 20% in a short span, increasing consolidation risk
Sentiment & News
Key News Insights:
- •Earnings Beat
- •Guidance Raise
- •Legal Overhang
Elevance Health's Q1 beat, raised guidance, and discounted valuation support the stock, though membership declines and legal investigations remain an overhang.
Strong operating results and a cheaper valuation look supportive for ELV, but governance and cost pressures could cap near-term upside
Similar Companies in Healthcare
Other companies in the same sector with AI ratings